Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Medical Action Industries (MDCI): Hedge Funds Are Bearish and Insiders Are Bullish, What Should You Do?

Medical Action Industries (NASDAQ:MDCI) shareholders have witnessed a decrease in hedge fund interest in recent months; in our experience, a stagnant interest is a bearish sign.

In the 21st century investor’s toolkit, there are dozens of gauges investors can use to monitor publicly traded companies. Some of the most under-the-radar are hedge fund and insider trading movement. At Insider Monkey, our research analyses have shown that, historically, those who follow the top picks of the top hedge fund managers can outpace the broader indices by a solid margin (see just how much).

Medical Action Industries (NASDAQ:MDCI)

Just as beneficial, optimistic insider trading activity is another way to break down the stock market universe. As the old adage goes: there are a variety of reasons for a corporate insider to drop shares of his or her company, but just one, very obvious reason why they would buy. Several empirical studies have demonstrated the useful potential of this strategy if investors understand where to look (learn more here).

With these “truths” under our belt, it’s important to take a peek at the recent action regarding Medical Action Industries (NASDAQ:MDCI).

How have hedgies been trading Medical Action Industries (NASDAQ:MDCI)?

At year’s end, a total of 6 of the hedge funds we track were bullish in this stock, a change of 0% from the third quarter. With hedge funds’ capital changing hands, there exists an “upper tier” of noteworthy hedge fund managers who were boosting their holdings meaningfully.

Seeing as Medical Action Industries (NASDAQ:MDCI) has faced falling interest from the entirety of the hedge funds we track, it’s easy to see that there exists a select few hedge funds that elected to cut their positions entirely at the end of the year. Interestingly, Ben Levine, Andrew Manuel and Stefan Renold’s LMR Partners dropped the largest investment of the 450+ funds we track, comprising an estimated $0.1 million in stock. These bearish behaviors are interesting, as total hedge fund interest stayed the same (this is a bearish signal in our experience).

Insider trading activity in Medical Action Industries (NASDAQ:MDCI)

Bullish insider trading is particularly usable when the company we’re looking at has seen transactions within the past half-year. Over the last half-year time period, Medical Action Industries (NASDAQ:MDCI) has experienced 1 unique insiders buying, and zero insider sales (see the details of insider trades here).

Let’s also review hedge fund and insider activity in other stocks similar to Medical Action Industries (NASDAQ:MDCI). These stocks are Solta Medical Inc (NASDAQ:SLTM), Zeltiq Aesthetics Inc (NASDAQ:ZLTQ), EDAP TMS S.A. (ADR) (NASDAQ:EDAP), Synergetics USA Inc (NASDAQ:SURG), and Rockwell Medical Inc (NASDAQ:RMTI). All of these stocks are in the medical appliances & equipment industry and their market caps resemble MDCI’s market cap.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.